TNF Pharma Partners on Breakthrough GLP-1 Muscle Loss Treatment, Eyes $105B Market Opportunity TNF Pharmaceuticals launches groundbreaking study for muscle preservation in GLP-1 patients, targeting massive market need. Could become first therapy for Wegovy-related muscle loss.

#TNFA #MYMD TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

www.stocktitan.net/news/TNFA/tnf-pharmaceut...